11.15

0.81% 0.09

Oric Pharmaceuticals Inc (ORIC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$11.06

Offen:

$11.08

24-Stunden-Volumen:

552.49K

Relative Volume:

0.50

Marktkapitalisierung:

$950.25M

Einnahmen:

Nettoeinkommen (Verlust:

$-119.87M

KGV:

-6.1602

EPS:

-1.81

Netto-Cashflow:

$-109.90M

1W Leistung:

+1.55%

1M Leistung:

+19.76%

6M Leistung:

+12.97%

1J Leistung:

+4.30%

1-Tages-Spanne:

$11.02

$11.40

1-Wochen-Bereich:

$10.83

$11.57

52-Wochen-Spanne:

$3.8951

$14.67

Oric Pharmaceuticals Inc Stock (ORIC) Company Profile

Firmenname

Oric Pharmaceuticals Inc

Sektor

Healthcare (1161)

Branche

Biotechnology (653)

Telefon

(650) 388-5600

Adresse

240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA

Mitarbeiter

122

Twitter

Nächster Verdiensttermin

2024-11-04

Neueste SEC-Einreichungen

ORIC's Discussions on Twitter

Vergleichen Sie ORIC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ORIC Oric Pharmaceuticals Inc	11.15	935.70M	0	-119.87M	-109.90M	-1.81
VRTX Vertex Pharmaceuticals Inc	470.13	119.21B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	560.93	59.16B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	325.28	40.57B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	571.23	34.02B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	295.59	29.19B	3.81B	-644.79M	-669.77M	-6.24

Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-08	Eingeleitet	Ladenburg Thalmann	Buy
2024-10-31	Eingeleitet	Wells Fargo	Overweight
2024-09-06	Eingeleitet	Stifel	Buy
2024-02-23	Eingeleitet	Cantor Fitzgerald	Overweight
2023-09-22	Eingeleitet	Wedbush	Outperform
2023-03-23	Hochstufung	H.C. Wainwright	Neutral → Buy
2023-03-21	Hochstufung	Guggenheim	Neutral → Buy
2023-03-16	Hochstufung	Oppenheimer	Perform → Outperform
2022-07-18	Fortgesetzt	Oppenheimer	Perform
2022-04-04	Hochstufung	Citigroup	Neutral → Buy
2022-03-25	Herabstufung	H.C. Wainwright	Buy → Neutral
2022-03-22	Herabstufung	Citigroup	Buy → Neutral
2022-03-22	Herabstufung	Guggenheim	Buy → Neutral
2022-03-22	Herabstufung	Oppenheimer	Outperform → Perform
2021-07-06	Hochstufung	Citigroup	Neutral → Buy
2021-01-25	Herabstufung	Citigroup	Buy → Neutral
2020-08-13	Eingeleitet	Robert W. Baird	Outperform
2020-08-06	Hochstufung	Citigroup	Neutral → Buy
2020-08-03	Eingeleitet	H.C. Wainwright	Buy
2020-05-19	Eingeleitet	Citigroup	Neutral
2020-05-19	Eingeleitet	Guggenheim	Buy
2020-05-19	Eingeleitet	JP Morgan	Overweight
2020-05-19	Eingeleitet	Jefferies	Buy

Alle ansehen

Oric Pharmaceuticals Inc Aktie (ORIC) Neueste Nachrichten

Jul 22, 2025

What analysts say about ORIC Pharmaceuticals Inc. stockBreakout stock performance - Autocar Professional

Jul 22, 2025

Is ORIC Pharmaceuticals Inc. a good long term investmentExceptional return forecasts - jammulinksnews.com

Jul 22, 2025

What drives ORIC Pharmaceuticals Inc. stock priceHigh-yield growth strategies - jammulinksnews.com

Jul 22, 2025

Jul 20, 2025

ORIC Pharmaceuticals Inc. Stock Analysis and ForecastFree Investment Community - printweek.in

Jul 20, 2025

Jul 18, 2025

How high can ORIC Pharmaceuticals Inc. stock price go in 2025Massive Gain Ideas - Newser

Jul 18, 2025

Jul 17, 2025

ORIC Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛

Jul 17, 2025

Jul 16, 2025

Why ORIC Pharmaceuticals Inc. stock attracts strong analyst attentionFree Capital Allocation Plans - Newser

Jul 16, 2025

Jul 15, 2025

What makes ORIC Pharmaceuticals Inc. stock price move sharplySmart High Yield Swing Trades - Newser

Jul 15, 2025

How ORIC Pharmaceuticals Inc. stock performs during market volatilityTop Growth Low Risk Stocks - Newser

Jul 15, 2025